Evkeeza Injection, Solution, Concentrate
Product Images NDC 61755-013

This appears to be a graph which shows "Percent change from Baseline" (DBTI) for two groups of patients - one who received a placebo and another who received a drug called EVKEEZA. The upper X-axis indicates the number of patients whereas the lower X-axis shows the duration of the treatment in weeks. However, due to the quality, the text is not very clear and some characters are missing or incorrectly recognized. Therefore, the interpretation might not be completely accurate.*

This is a description of a pharmaceutical product with the name "Evkeeza". It comes in a single-dose vial that contains 345 mg of solution. Each vial contains 150 mg of evinacumab-dgnb, L-erghine hydrochloride, L-Histidine, L-istidine monohydrochloride monohydrate, L-proline, polysorbate 80, and Water for injection. It is recommended to use 0.9% Sodium Chloride or 5% Dextrose to dilute the solution before use. The product must be stored at refrigerated temperatures between 2°C to 8°C and must not be frozen or shaken. The dosage of the product can be found in the prescribing information. The product is sterile and free from preservatives.*

Product name: Evkeeza™ Evkeeza is a medication that comes in a single-dose vial. Each vial contains 1200 mg of evinacumab-dgnb, L-arginine hydrochloride, L-lysine acetate, L-histidine monohydrochloride monohydrate, L-proline and 50 mg of polysorbate 80. It is used for intravenous infusion after dilution. The recommended solvents for dilution are 0.9% Sodium Chloride or 5% Dextrose. It should be stored under refrigeration at 2°C to 8°C (36°F to 46°F). The dosage should be decided by a medical practitioner. It is a sterile solution and the unused portion should be discarded. If the seal of the vial is broken or it is missing, it should not be used. If it is past its expiry, it should not be used.*